Average Co-Inventor Count = 3.33
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Oncotherapy Science, Incorporated (14 from 148 patents)
2. The University of Tokyo (2 from 1,278 patents)
3. University of Pittsburgh (1 from 1,860 patents)
17 patents:
1. 12263197 - Oncolytic virus for cancer therapy
2. 9226934 - Anti-cancer drug
3. 8674059 - Colon cancer related gene TOM34
4. 8663647 - Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
5. 8614176 - Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
6. 8574585 - KDR peptides and vaccines comprising the same
7. 8574586 - KDR peptides and vaccines comprising the same
8. 8257711 - Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
9. 8206719 - KDR peptides and vaccines comprising the same
10. 7919099 - Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11. 7847065 - CXADRL1 polypeptides relating to human cancers
12. 7847060 - Peptide vaccines for lung cancers expressing TTK, URLC10 or KOC1 polypeptides
13. 7705141 - Genes and polypeptides relating to human colon cancers
14. 7695720 - KDR peptides and vaccines comprising the same
15. 7514084 - KDR peptides and vaccines comprising the same